● Recruiting

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

Condition: Irritable Bowel Syndrome · Sponsor: GlaxoSmithKline

PhasePhase 2

Planned participants420

Who can joinAll sexes, 18 Years to 80 Years

Healthy volunteersNo

About this study

This study is designed to evaluate the efficacy and safety of camlipixant in adults with IBS-D and IBS-M. The study has two parts. After the first part, some participants will be randomly chosen again to either get a higher dose or stop the drug.

This description comes directly from the study's public registry record.

Talk to the study team

US GSK Clinical Trials Call Center · 877-379-3718 · GSKClinicalSupportHD@gsk.com

EU GSK Clinical Trials Call Center · +44 (0) 20 89904466 · GSKClinicalSupportHD@gsk.com

Always discuss trial participation with your own doctor first.

Locations (110)

GSK Investigational Site	Anniston, Alabama, United States	Recruiting
GSK Investigational Site	Guntersville, Alabama, United States	Recruiting
GSK Investigational Site	Mobile, Alabama, United States	Recruiting
GSK Investigational Site	Saraland, Alabama, United States	Recruiting
GSK Investigational Site	Scottsdale, Arizona, United States	Recruiting
GSK Investigational Site	Tempe, Arizona, United States	Recruiting
GSK Investigational Site	Anaheim, California, United States	Recruiting
GSK Investigational Site	Chula Vista, California, United States	Recruiting
GSK Investigational Site	Coronado, California, United States	Recruiting
GSK Investigational Site	Garden Grove, California, United States	Recruiting
GSK Investigational Site	Lancaster, California, United States	Recruiting
GSK Investigational Site	Lancaster, California, United States	Recruiting

+ 98 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07519395